NovaBay Pharma's total assets for Q1 2025 were $9.87M, an increase of 188.40% from the previous quarter. NBY total liabilities were $3.71M for the fiscal quarter, a 4.31% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.